Diabetes

Top Story

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016

In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor enalapril, according to new data from the ATMOSPHERE trial.

In the overall results, presented in April, aliskiren (Tekturna, Novartis) alone or combined with enalapril did not improve CV mortality or hospitalization for HF compared with enalapril alone.

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause, according to a…
Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the National Lipid…
Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate obesity and type 2…
CME

The Patient With Atrial Fibrillation

No commercial support for this activity.

Atrial fibrillation is the most common type of tachyarrhythmia and is characterized by disorganization of the heart’s…
More »
Video
Meeting News Coverage

VIDEO: Extended-release aspirin provides stable antiplatelet effect

November 14, 2015
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
More »
Meeting News Coverage

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016
In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor…

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause…

Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the…

Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate…

Meeting News CoverageVideo

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
ORLANDO, Fla. — Bronwyn Kingwell, PhD, head of metabolic and vascular physiology at Baker IDI Heart and Diabetes Institute, Melbourne…

Meeting News Coverage

Femoropopliteal DCB effective in women, patients with diabetes, CTO

May 4, 2016
A drug-coated balloon was effective in women, in patients with diabetes and in those with chronic total occlusions, according to new data.Analyses of…

In the Journals

Intensive glycemic control preserves muscle strength in patients with type 2 diabetes, heart failure

May 3, 2016
In patients with type 2 diabetes and chronic heart failure, 4 months of intensive glycemic control had no adverse effect on left ventricular…

Abbott to acquire St. Jude Medical

April 28, 2016
Abbott announced that it will acquire St. Jude Medical in an effort to enhance its global scale and diversify its portfolio.With the acquisition…

Meeting News Coverage

PEGASUS-TIMI 54: Long-term ticagrelor benefits patients with history of MI, diabetes, PAD

April 28, 2016
CHICAGO — Two subanalyses of the PEGASUS-TIMI 54 study of stable patients with prior MI showed that ticagrelor reduced major adverse CV events…

In the Journals

Lipid-lowering therapy reduces risk for CVD, death in type 1 diabetes

April 26, 2016
People with type 1 diabetes without a history of cardiovascular disease may have reduced risk for cardiovascular disease and cardiovascular death…

More Headlines »
morganatic-roan morganatic-roan